A Multi-Model Machine Learning Framework for Identifying Raloxifene as a Novel RNA Polymerase Inhibitor from FDA-Approved Drugs
RNA-dependent RNA polymerase (RdRP) represents a critical target for antiviral drug development. We developed a multi-model machine learning framework combining five traditional algorithms (ExtraTreesClassifier, RandomForestClassifier, LGBMClassifier, BernoulliNB, and BaggingClassifier) with a CNN d...
Saved in:
| Main Authors: | Nhung Thi Hong Van, Minh Tuan Nguyen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/47/5/315 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposing FDA-approved drugs and natural compounds to inhibit the RNA-dependent RNA polymerase domain of dengue virus 2 or dengue virus 3
by: Khadijeh Ahmadi, et al.
Published: (2025-04-01) -
Identification of Benzothiophene-Derived Inhibitors of Flaviviruses by Targeting RNA-Dependent RNA Polymerase
by: Leah Liu Wang, et al.
Published: (2025-01-01) -
The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01) -
Raloxifene as an Adjuvant Therapy for Patients With Schizophrenia: An Up‐To‐Date Systematic Review and Meta‐Analysis
by: Tzu‐Rong Peng, et al.
Published: (2025-07-01) -
RNA interference of Aspergillus flavus in response to Aspergillus flavus partitivirus 1 infection
by: Yinhui Jiang, et al.
Published: (2023-11-01)